Related Experiment Video
Updated: Aug 11, 2026

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
Glucagon binding to receptors on the surface of chicken adipocytes
1Agricultural Research Service, USDA, Georgetown, DE 19947, USA.
Abstract:
Adipocytes isolated from abdominal fat of chickens were used 1) to demonstrate that [125I]-tyr10-glucagon binds with all the characteristics of a hormone-receptor interaction and 2) to determine whether glucagon binds to one or more receptor sites. Binding of [125I]-tyr10-glucagon was characterized at 12 degrees C, a temperature found to completely inhibit internalization of the radioligand. Culturing adipocytes increased radioligand binding by 60 to 100% and, therefore, fat cells were incubated for 72 h before characterizing binding. Binding of [125I]-tyr10-glucagon to chicken adipocytes reached steady-state, was reversible, was specific for glucagon, was saturable, and increased linearly as a function of fat cell concentration. Both kinetic and steady-state experiments indicated that [125I]-tyr10-glucagon bound to two sites on chicken adipocytes. Equilibrium dissociation constants (Kd) of 54 +/- 16 pM and 3.3 +/- 1.3 nM were obtained for [125I]-tyr10-glucagon, whereas Kd of .49 and 81 nM were calculated for mammalian glucagon. There were 4,831 +/- 1,057 high-affinity receptors and 200,780 +/- 63,404 low-affinity receptors per adipocyte. Thus, only 2.3% of the glucagon binding sites were of high affinity. In addition to higher binding affinity, [125I]-tyr10-glucagon stimulated glycerol release from chicken adipocytes with greater potency than porcine glucagon. Therefore, it was concluded that [125I]-tyr10-glucagon was a supra-agonist that bound to high- and low-affinity receptors on the surface of chicken adipocytes with all the characteristics of a hormone-receptor interaction.
Related Concept Videos
Cell Specific Gene Expression
Insulin Secretory Vesicles
GPCRs Regulate Adenylyl Cylase Activity
Two...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Insulin: The Receptor and Signaling Pathways
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...

